Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lokiec

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Harefuah|August 1, 1991
[Fractures of the proximal femur]A U Eshkenazi, F Lokiec, U Giveon, et al.
Pathologie-Biologie|April 1, 1995
[Penetration of ceftriaxone (1 or 2 gr intravenous) into mediastinal and cardiac tissues in man]X Viviand, M Alaya, F Lokiec, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Pharmacokinetics of oral acyclovir in neonates and in infants: a population analysisM Tod, F Lokiec, R Bidault, et al.
Bulletin Du Cancer|January 1, 1989
[Interspecies comparison of pharmacokinetic parameters of fotemustine (nitrosourea S 10036): mice, rats, monkeys, dogs and man]C Lucas, B Ings, A J Gray, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Exacerbation of oxaliplatin neurosensory toxicity following surgeryJ-M Gornet, E Savier, F Lokiec, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1992
Effects of diclofenac on ceftriaxone pharmacokinetics in humansM Merle-Melet, L Bresler, F Lokiec, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trialsL P Rivory, M C Haaz, P Canal, et al.
International Journal of Nuclear Medicine and Biology|January 1, 1984
Cancer treatment by methotrexate: rational use following pharmacokinetic studyF Lokiec, B Clavel, L Meeus, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1992
Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgeryC Martin, J Ragni, F Lokiec, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Pharmacokinetics and pharmacodynamics of nitrosourea fotemustine: a French cancer centre multicentric studyA Iliadis, M C Launay-Iliadis, C Lucas, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Harefuah|August 1, 1991
[Fractures of the proximal femur]A U Eshkenazi, F Lokiec, U Giveon, et al.
Pathologie-Biologie|April 1, 1995
[Penetration of ceftriaxone (1 or 2 gr intravenous) into mediastinal and cardiac tissues in man]X Viviand, M Alaya, F Lokiec, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Pharmacokinetics of oral acyclovir in neonates and in infants: a population analysisM Tod, F Lokiec, R Bidault, et al.
Bulletin Du Cancer|January 1, 1989
[Interspecies comparison of pharmacokinetic parameters of fotemustine (nitrosourea S 10036): mice, rats, monkeys, dogs and man]C Lucas, B Ings, A J Gray, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Exacerbation of oxaliplatin neurosensory toxicity following surgeryJ-M Gornet, E Savier, F Lokiec, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1992
Effects of diclofenac on ceftriaxone pharmacokinetics in humansM Merle-Melet, L Bresler, F Lokiec, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trialsL P Rivory, M C Haaz, P Canal, et al.
International Journal of Nuclear Medicine and Biology|January 1, 1984
Cancer treatment by methotrexate: rational use following pharmacokinetic studyF Lokiec, B Clavel, L Meeus, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1992
Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgeryC Martin, J Ragni, F Lokiec, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Pharmacokinetics and pharmacodynamics of nitrosourea fotemustine: a French cancer centre multicentric studyA Iliadis, M C Launay-Iliadis, C Lucas, et al.
Pageof 12